Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2021-04-13
Product name
CareStart TM COVID-19 Antigen
CAS No.
26628-22-8
1.2.1 Relevant identified uses
▪ In vitro Rapid Diagnostic test for qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in an nasopharyngeal or nasal swab specimens directly collected ▪ This kit is for in vitro diagnostic use only
Emergency telephone
+1 (732) 873 4040, +1 (732) 873 4043
Icons in SDS
Company Information
company name
Access Bio, Inc
Section 2
SECTION 2: Hazards identification
Emergency Overview: ▪ No significant health effects are anticipated from using this product when used under normal operating conditions and in accordance with the kit specific instructions for use. ▪ Although sodium azide is included as a preservative in the nitrocellulose membrane, it is not considered as hazardous at this concentration (<0.1%) according to the latest edition of Globally Harmonized System of Classification and Labeling of Chemicals (GHS). ▪ Repeated or prolonged exposure is not known to aggravate any medical condition. Extraction Solution: ▪ Eye Contact: Irritation. Tears. ▪ Skin Contact: Irritation. ▪ Ingestion: No known significant effect or critical hazard upon ingestion of extraction vial in the kit. ▪ Inhalation: None known.
